# Sami Mikati

> Sami Mikati is a seed investor backing Biotechnology and Software. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 2
- Last investment: Jun 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sami-mikati-904a03

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

## Contacts

5 contacts available for Sami Mikati: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/sami-mikati?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $900k–$1.4M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Software | 1 | 50% |
| Life Science | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CyGenica | CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. | $1.4M | Seed | Jun 08, 2021 | https://www.cygenica.com/ |
| Synthace | Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all oftheir experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible. | $900K | Seed | Apr 12, 2013 | https://www.synthace.com |

2 of 2 investments shown.

## Co-investors
- [Angels 5K](https://shizune.co/investors/profile/angels-5k-3b74) — VC Fund, 1 deal together
- [Golden Sparrow Ventures](https://shizune.co/investors/profile/golden-sparrow-ventures) — VC Fund, 1 deal together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 1 deal together
- [VOYAGERS Health-Tech Fund](https://shizune.co/investors/profile/voyagers-health-tech-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Biotech Investors in India](https://shizune.co/investors/biotech-investors-india)
- [Biotech Angel Investors in United Kingdom](https://shizune.co/investors/biotech-angel-investors-united-kingdom)
- [Climate Angel Investors in United Kingdom](https://shizune.co/investors/climate-angel-investors-united-kingdom)
- [Biotech Angel Investors in India](https://shizune.co/investors/biotech-angel-investors-india)
- [Manufacturing Angel Investors in United Kingdom](https://shizune.co/investors/manufacturing-angel-investors-united-kingdom)
- [Biotechnology Investors in India](https://shizune.co/investors/biotechnology-investors-india)

## FAQ

### What does Sami Mikati invest in?

Sami Mikati invests primarily in Biotechnology, Software and Life Science startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sami Mikati's check size?

Sami Mikati typically joins rounds of $900k–$1.4M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sami Mikati participates in.

### How do I contact Sami Mikati?

Public channels for Sami Mikati include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Sami Mikati last invest?

The most recent investment recorded for Sami Mikati closed in Jun 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co